InsidersTradesSigma
Molecular Partners Ltd Stock: price and directors' dealings · Switzerland · SIX SER
Follow the Molecular Partners Ltd share price and the full insider trade history of the company, a publicly traded company based in Switzerland. Shares are quoted on CH CH, under the oversight of SIX SER. Operating in the Health Care sector, Molecular Partners Ltd has published 0 reports. Market capitalisation: €125.3m. The full history is accessible without an account.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Molecular Partners Ltd Buy (bullish), based on 2 analysts. Average price target: CHF 9.00.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Molecular Partners Ltd
Molecular Partners Ltd is a Swiss biopharmaceutical company focused on developing protein-based therapies. It is listed on the Swiss stock exchange XSWX.